Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

NCT00091702

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +16 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Univ. of South Alabama College of Medicine, Southeast Ped. ACTU Mobile, Alabama, United States
  • Phoenix Children's Hosp. Phoenix, Arizona, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
View all 61 locations
View Trial Details
Completed

Safety and Acceptability of a Vaginal Microbicide

NCT00111943

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +24 more
Locations
  • Alabama Microbicide CRS Birmingham, Alabama, United States
  • Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS) The Bronx, New York, United States
  • NARI Arogya Aadhar Clinic CRS Pune, Maharashtra, India
View Trial Details
Completed

Growth Hormone Treatment of Children With HIV-Associated Growth Failure

NCT00006143

Conditions
Blood-Borne Infections, Communicable Diseases, Developmental Disabilities, +14 more
Locations
  • Phoenix Children's Hosp. Phoenix, Arizona, United States
  • Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • South Florida CDC Ft Lauderdale NICHD CRS Fort Lauderdale, Florida, United States
View all 20 locations
View Trial Details
Completed

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

NCT00008463

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +23 more
Locations
  • Ucsd, Avrc Crs San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV

NCT00001049

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Long Beach Memorial (Pediatric) Long Beach, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 47 locations
View Trial Details
Completed

Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants

NCT00076791

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Children's National Med. Ctr. Washington DC NICHD CRS Washington D.C., District of Columbia, United States
  • Washington Hosp. Ctr. NICHD CRS Washington D.C., District of Columbia, United States
  • Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami, Florida, United States
  • Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program Chicago, Illinois, United States
View Trial Details
Completed

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

NCT00001030

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View all 42 locations
View Trial Details
Completed

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

NCT00039975

Conditions
Blood-Borne Infections, Cardiovascular Diseases, Communicable Diseases, +14 more
Locations
  • Univ of California San Francisco San Francisco, California, United States
  • Stanford Univ Med Ctr Stanford, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Johns Hopkins Hosp Baltimore, Maryland, United States
View Trial Details
Completed

Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

NCT00099671

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ. of California Davis Med. Ctr., ACTU Sacramento, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Case CRS Cleveland, Ohio, United States
View Trial Details

Related conditions